RAD Regimen Increases Bone Formation and Reduces Bone Resorption and Angiogenesis in Patients with Newly Diagnosed Myeloma: Results of a Phase 2 Study

Evangelos Terpos; Eirini Katodritou; Argiris Symeonidis; Flora Zagouri; Antonis Gerofotis; Georgia Christopoulou; Maria Gavriatopoulou; Dimitrios Christoulas; Alexandra Kourakli; Pavlina Konstantinidou; Efstathios Kastritis; Meletios A Dimopoulos

doi:10.1016/j.clml.2017.03.258

Related publications

Article2009

High Serum Sclerostin Correlates with Advanced Stage, Increased Bone Resorption, Reduced Osteoblast Function, and Poor Survival in Newly-Diagnosed Patients with Multiple Myeloma.

Evangelos Terpos, Dimitrios Christoulas, Eirini Katodritou, Cornelia Bratengeier, Brigitte Lindner, Silvia Harmelin, Gerhard Hawa, Georgios Boutsikas, Magdalini Migkou, Maria Gavriatopoulou, Eurydiki Michalis, Anastasia Pouli, Efstathios Kastritis, Konstantinos Zervas, Meletios A Dimopoulos

Article2024

Belantamab mafodotin, lenalidomide and dexamethasone in transplant-ineligible patients with newly diagnosed multiple myeloma: Part 1 results of a phase I/II study

Evangelos Terpos, Maria Gavriatopoulou, Ioannis Ntanasis‐Stathopoulos, Panagiotis Malandrakis, Despina Fotiou, Magdalini Migkou, Foteini Theodorakakou, Vasiliki Spiliopoulou, Ioannis V. Kostopoulos, Rodanthi‐Eleni Syrigou, Evangelos Eleutherakis‐Papaiakovou, Stavros Gkolfinopoulos, Ourania Tsitsilonis, Efstathios Kastritis, Meletios A Dimopoulos

Article2019

Effect of induction therapy with lenalidomide, doxorubicin and dexamethasone on bone remodeling and angiogenesis in newly diagnosed multiple myeloma

Evangelos Terpos, Eirini Katodritou, Argiris Symeonidis, Flora Zagouri, Antonis Gerofotis, Georgia Christopoulou, Maria Gavriatopoulou, Dimitrios Christoulas, Ioannis Ntanasis‐Stathopoulos, Alexandra Kourakli, Pavlina Konstantinidou, Efstathios Kastritis, Meletios A Dimopoulos

Article2013

PFS2 In Elderly Patients With Newly Diagnosed Multiple Myeloma (NDMM): Results From The MM-015 Study

Meletios A Dimopoulos, Maria Teresa Petrucci, Robin Foà, John Catalano, Martin Kropff, Zhinuan Yu, Lara Grote, Christian Jacques, Antonio Palumbo

Article2025

Belantamab Mafodotin plus Lenalidomide/Dexamethasone in Newly Diagnosed Patients with Multiple Myeloma: Long-Term Efficacy and Safety Results from the Phase 1/2 BelaRd Study

Evangelos Terpos, Maria Gavriatopoulou, Ioannis Ntanasis‐Stathopoulos, Nikolaos Kanellias, Eirini Solia, Panagiotis Malandrakis, Vasiliki Spiliopoulou, Foteini Theodorakakou, Magdalini Migkou, Evangelos Eleutherakis Papaiakovou, Despina Fotiou, Giorgos Psarros, Efstathios Kastritis, Meletios A Dimopoulos